Abstract
Mutation analysis of latent membrane protein 1 (LMP1) in Epstein-Barr virus (EBV)-induced B-cell immortalization revealed two transformation effector sites, TES1 and TES2. TES2 mediates the interaction with tumor necrosis factor receptor-associated death domain protein (TRADD) and plays a key role in transactivating NF-kappa B and AP-1. Recombinant EBV containing LMP1 with TES2 deleted induces a limited proliferation of B cells. The present study shows that a mutant with an LMP1 site-specific mutation at TES2, LMP1(TRADD), initially stimulates cell growth and significantly extends the life span of MEF. However, it is not sufficient for the immortalization of MEF, and MEF-LMP1(TRADD) cells eventually enter growth arrest. Further analysis reveals that although LMP1(TRADD) promotes cell growth, it does not prevent the eventual onset of senescence and the expression of tumor suppressor p16(Ink4a).
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Cell Division
-
Cell Transformation, Viral*
-
Cells, Cultured
-
Cellular Senescence
-
Cyclin-Dependent Kinase Inhibitor p16 / metabolism
-
DNA Mutational Analysis
-
Fibroblasts
-
Herpesvirus 4, Human / genetics
-
Herpesvirus 4, Human / physiology*
-
Mice
-
Protein Structure, Tertiary
-
Proteins / chemistry*
-
Proteins / genetics
-
Proteins / metabolism
-
TNF Receptor-Associated Death Domain Protein
-
TNF Receptor-Associated Factor 1
-
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins*
-
Viral Matrix Proteins / chemistry
-
Viral Matrix Proteins / genetics*
-
Viral Matrix Proteins / metabolism
Substances
-
Cyclin-Dependent Kinase Inhibitor p16
-
EBV-associated membrane antigen, Epstein-Barr virus
-
Proteins
-
TNF Receptor-Associated Death Domain Protein
-
TNF Receptor-Associated Factor 1
-
Tradd protein, mouse
-
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins
-
Viral Matrix Proteins